Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06439706
Other study ID # 23-1027
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 4, 2023
Est. completion date December 31, 2025

Study information

Verified date May 2024
Source Fox Chase Cancer Center
Contact Carolyn Fang, PhD
Phone 2157284062
Email carolyn.fang@fccc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to learn if women of Hispanic/Latina ethnicity are willing to self-collect a cervico-vaginal sample for HPV testing. The main question the study will answer is: • Does a brief educational intervention increase the feasibility and acceptability of HPV self-sampling among Hispanic/Latina women? The study team will compare whether including a brief educational intervention with a mailed HPV self-sampling kit is more acceptable than receiving a mailed HPV self-sampling kit alone. Participants will be asked to complete surveys at study entry (baseline) and then randomized to receive only the HPV self-sampling kit, or the kit plus a small group education that meets with a bilingual health educator. Participants will then be contacted about one-month later to complete a follow-up survey. The study team will also measure the number of participants in each group who self-collect a sample and mail it in for HPV testing.


Description:

We will recruit a sample of underscreened Latinas (n=100) who will be randomly assigned to either the educational intervention (n=50) or a control condition (n=50). Feasibility will be measured through study enrollment and intervention completion (defined as the proportion of women who self-collect a sample). Acceptability of intervention materials and self-sampling procedures will be measured using self-report surveys at follow-up assessments.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 31, 2025
Est. primary completion date September 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 30 Years to 65 Years
Eligibility Inclusion Criteria: - Self-reported Hispanic/Latina ethnicity - Assigned female sex at birth - Age 30-65, consistent with guidelines for HPV DNA testing for cervical cancer screening - Speak and read English or Spanish - Computer or other device with internet connection - Overdue for cervical cancer screening (e.g., no cytology-based screening within the past 3 years; no hrHPV testing either alone or in combination with cytology in the past 5 years). Exclusion Criteria: - Prior diagnosis of cervical cancer or abnormality (e.g., dysplasia) - Had a hysterectomy/removal of the cervix - Compromised immune system (e.g., known HIV) - Women who self-report that they are pregnant or are within three months after a pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
HPV Self-Sampling
HPV self-sampling kit
Group Education
Small-group education led by bilingual health educator

Locations

Country Name City State
United States Fox Chase Cancer Center Philadelphia Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Fox Chase Cancer Center Pennsylvania Breast Cancer Coalition

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility The number of participants who attend at least one session in the intervention arm 1 month
Secondary Participation in screening The number of participants who return a self-collected sample 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT04114968 - Offering Cervical Cancer Screening to Older Women
Active, not recruiting NCT05682950 - Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer Phase 2
Completed NCT05022511 - Three Birds With One Stone N/A
Active, not recruiting NCT05869123 - Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer Phase 1/Phase 2
Recruiting NCT03739944 - Different Surgical Approaches in Patients of Early-stage Cervical Cancer Phase 3
Terminated NCT03020121 - Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples N/A
Completed NCT04679675 - Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial N/A
Active, not recruiting NCT03994055 - Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer N/A
Recruiting NCT03955185 - Clinical Trial of Minimally Invasive Surgery Versus Abdominal Surgery in Patients With Early Stage Cervical Cancer N/A
Recruiting NCT04974424 - Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV
Recruiting NCT03308591 - Clinical Efficacy of the Neoadjuvant Chemotherapy for IB2 and IIA2 Stage Cervical Cancer Patients Phase 3
Active, not recruiting NCT05880485 - Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer Phase 1/Phase 2
Terminated NCT03100409 - Effect of a Low Residue Diet in Comparison to the Dietetic Recommendations From the INCan in Cervical Cancer Patients N/A
Not yet recruiting NCT03971032 - An In-vitro Real-time System Based on Tissue Smears to Identify Malignancy During Hysteroscopic Procedure N/A
Recruiting NCT04516616 - Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Phase 2
Recruiting NCT04061967 - SMS-based Summons in Cervical Screening N/A
Completed NCT03122275 - Stepwise Strategy to Improve CANcer Screening Adherence: Cervical Cancer N/A